171 related articles for article (PubMed ID: 36344703)
1. Usefulness of SynCAM3 and cyclin D1 immunohistochemistry in distinguishing superficial CD34-positive fibroblastic tumor from its histological mimics.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Murahashi Y; Emori M; Tsuyuki A; Hasegawa T
Med Mol Morphol; 2023 Mar; 56(1):69-77. PubMed ID: 36344703
[TBL] [Abstract][Full Text] [Related]
2. Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlapping entities: a comprehensive study of 20 cases.
Perret R; Michal M; Carr RA; Velasco V; Švajdler M; Karanian M; Meurgey A; Paindavoine S; Soubeyran I; Coindre JM; Boidot R; Charon-Barra C; Geneste D; Weingertner N; Pissaloux D; Tirode F; Baud J; Le Loarer F
Histopathology; 2021 Nov; 79(5):810-825. PubMed ID: 34121219
[TBL] [Abstract][Full Text] [Related]
3. Superficial CD34-Positive Fibroblastic Tumor on the Chest Wall of an 8-Year-Old Girl: A Case Report and Literature Review.
Li SY; Zhang HL; Bai YZ
Pediatr Hematol Oncol; 2021 Sep; 38(6):602-608. PubMed ID: 33792506
[TBL] [Abstract][Full Text] [Related]
4. Superficial CD34-Positive Fibroblastic Tumor: A Clinicopathologic, Immunohistochemical, and Molecular Study of 59 Cases.
Anderson WJ; Mertens F; Mariño-Enríquez A; Hornick JL; Fletcher CDM
Am J Surg Pathol; 2022 Oct; 46(10):1329-1339. PubMed ID: 35713642
[TBL] [Abstract][Full Text] [Related]
5. Recurrent PRDM10 Fusions in Superficial CD34-Positive Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 10 Additional Cases of an Emerging Novel Entity.
Zhao M; Yin X; He H; Fan Y; Ru G; Meng X
Am J Clin Pathol; 2023 Apr; 159(4):367-378. PubMed ID: 36812381
[TBL] [Abstract][Full Text] [Related]
6. Case of recurrent superficial CD34-positive fibroblastic tumor.
Salah HT; D'Ardis JA; Baek D; Duran J; Schwartz MR; Ayala AG; Ro JY
J Cutan Pathol; 2023 Jun; 50(6):477-480. PubMed ID: 36107756
[TBL] [Abstract][Full Text] [Related]
7. Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F; Carter JM; Pillay N; McCulloch TA; Sumathi VP; Rissler P; Fagman H; Hansson M; Amary F; Tirabosco R; Magnusson L; Nilsson J; Flanagan AM; Folpe AL; Mertens F
Mod Pathol; 2022 Jun; 35(6):767-776. PubMed ID: 34969957
[TBL] [Abstract][Full Text] [Related]
8. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical features.
Salah HT; D'ardis JA; Baek D; Schwartz MR; Ayala AG; Ro JY
Ann Diagn Pathol; 2022 Jun; 58():151937. PubMed ID: 35344860
[TBL] [Abstract][Full Text] [Related]
9. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
10. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract][Full Text] [Related]
11. Superficial CD34-Positive Fibroblastic Tumor.
Foot O; Hallin M; Bagué S; Jones RL; Thway K
Int J Surg Pathol; 2020 Dec; 28(8):879-881. PubMed ID: 32608310
[TBL] [Abstract][Full Text] [Related]
12. Superficial CD34-Positive Fibroblastic Tumor: A Newly Recognized Entity With Overlapping Features of PRDM10-Rearranged Soft Tissue Tumors.
Shaker N; Abu Shakra R; Sangueza OP
Cureus; 2023 Oct; 15(10):e47831. PubMed ID: 38021590
[TBL] [Abstract][Full Text] [Related]
13. PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
Puls F; Pillay N; Fagman H; Palin-Masreliez A; Amary F; Hansson M; Kindblom LG; McCulloch TA; Meligonis G; Muc R; Rissler P; Sumathi VP; Tirabosco R; Hofvander J; Magnusson L; Nilsson J; Flanagan AM; Mertens F
Am J Surg Pathol; 2019 Apr; 43(4):504-513. PubMed ID: 30570551
[TBL] [Abstract][Full Text] [Related]
14. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
15. Superficial CD34 fibroblastic tumors and PRDM10-rearranged soft tissue neoplasm: An evolving diagnosis.
Johnson C; Parsa L; Gibbs J; Sligh J
J Cutan Pathol; 2024 Jan; 51(1):11-14. PubMed ID: 37150806
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
17. Superficial CD34-positive fibroblastic tumor in the forearm of a middle-aged patient: A newly described, rare soft-tissue tumor.
Rekhi B; Banerjee D; Gala K; Gulia A
Indian J Pathol Microbiol; 2018; 61(3):421-424. PubMed ID: 30004071
[TBL] [Abstract][Full Text] [Related]
18. Myxoinflammatory fibroblastic sarcoma: ultrastructural study of 7 cases.
Corredor-Alonso GE; Caro-Sánchez CHS; Domínguez-Malagón HR
Ultrastruct Pathol; 2024 Jan; 48(1):75-79. PubMed ID: 38126325
[TBL] [Abstract][Full Text] [Related]
19. Superficial mesenchymal tumours expressing epithelial markers on immunohistochemistry: Diagnostic clues and pitfalls.
Andrei V; Haefliger S; Baumhoer D
Semin Diagn Pathol; 2023 Jul; 40(4):238-245. PubMed ID: 37147159
[TBL] [Abstract][Full Text] [Related]
20. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
